These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 24118160)

  • 1. ¹⁸F-Fluorodeoxyglucose uptake and clinicopathological features of recurrent or metastatic endometrial stromal sarcoma.
    Inoue K; Tsubamoto H; Kawata S; Hao H; Ikeda Y; Oku N; Hirota S
    J Obstet Gynaecol Res; 2014 Feb; 40(2):576-82. PubMed ID: 24118160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of (18)F-FDG imaging and serum tumor markers in the diagnosis of recurrent endometrial carcinoma].
    Wang Q; Hong L; Wang JL; Yue MG; Li HB; Li Y
    Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):300-3. PubMed ID: 20510085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volume-based parameters of 18F-fluorodeoxyglucose positron emission tomography/computed tomography improve disease recurrence prediction in postmastectomy breast cancer patients with 1 to 3 positive axillary lymph nodes.
    Nakajima N; Kataoka M; Sugawara Y; Ochi T; Kiyoto S; Ohsumi S; Mochizuki T
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):738-46. PubMed ID: 24064322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [FDG-PET and endometrial cancer].
    Kolesnikov-Gauthier H; Carpentier P
    Bull Cancer; 2012 Jan; 99(1):21-8. PubMed ID: 22182739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography with (18)F-fluorodeoxyglucose of uterine sarcoma: a comparison with magnetic resonance imaging and power Doppler imaging.
    Umesaki N; Tanaka T; Miyama M; Kawamura N; Ogita S; Kawabe J; Okamura T; Koyama K; Ochi H
    Gynecol Oncol; 2001 Mar; 80(3):372-7. PubMed ID: 11263934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission mammography: correlation of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status and 18F-FDG.
    Wang CL; MacDonald LR; Rogers JV; Aravkin A; Haseley DR; Beatty JD
    AJR Am J Roentgenol; 2011 Aug; 197(2):W247-55. PubMed ID: 21785049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between the expression of oestrogen receptor and progesterone receptor and
    Wu C; Chen R; Xu L; Chen Y; Wang Y; Huang G; Liu J
    Aging (Albany NY); 2020 Jul; 12(13):12921-12929. PubMed ID: 32639950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial stromal sarcomas with unusual histologic features: a report of 24 primary and metastatic tumors emphasizing fibroblastic and smooth muscle differentiation.
    Yilmaz A; Rush DS; Soslow RA
    Am J Surg Pathol; 2002 Sep; 26(9):1142-50. PubMed ID: 12218570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade endometrial stromal sarcoma: hormonal aspects.
    Chu MC; Mor G; Lim C; Zheng W; Parkash V; Schwartz PE
    Gynecol Oncol; 2003 Jul; 90(1):170-6. PubMed ID: 12821359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDG PET/CT appearance of tumor thrombus of ovarian vessels masquerading as retroperitoneal fibrosis.
    Luo Y; Feng R; Li F
    Clin Nucl Med; 2015 Jun; 40(6):501-3. PubMed ID: 25546209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H; Henderson RW; Conti PS
    J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography imaging of oestrogen receptor-expression in endometrial stromal sarcoma supports oestrogen receptor-targeted therapy: case report and review of the literature.
    van Kruchten M; Hospers GA; Glaudemans AW; Hollema H; Arts HJ; Reyners AK
    Eur J Cancer; 2013 Dec; 49(18):3850-5. PubMed ID: 24007820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of estrogen, progesterone, and C-erbB-2 receptor states on 18F-FDG uptake of primary breast cancer lesions.
    Mavi A; Cermik TF; Urhan M; Puskulcu H; Basu S; Yu JQ; Zhuang H; Czerniecki B; Alavi A
    J Nucl Med; 2007 Aug; 48(8):1266-72. PubMed ID: 17631558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JAZF1-SUZ12 endometrial stromal sarcoma forming subserosal masses with extraordinary uptake of fluorodeoxyglucose on positron emission tomography: a case report.
    Fujiishi K; Nagata S; Kano R; Kubo C; Shirayanagi M; Ozaki M; Yamamoto T; Nakanishi K; Kamiura S; Nakatsuka SI
    Diagn Pathol; 2019 Oct; 14(1):110. PubMed ID: 31615558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial Stromal Sarcoma Arising from Endometrial Polyp: A Case Report.
    Sato S; Ojima Y; Kanda M; Kizaki T; Ohara N
    Kobe J Med Sci; 2018 Sep; 64(2):E36-E42. PubMed ID: 30381725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial stromal sarcoma involving the urinary bladder: a study of 6 cases.
    Tian W; Latour M; Epstein JI
    Am J Surg Pathol; 2014 Jul; 38(7):982-9. PubMed ID: 24705317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic endometrial stromal sarcoma of the lung: importance of immunohistochemical staining, clinical history and imaging studies.
    Mentrikoski MJ; Zhao C; Zhang J; Wang HL; McMahon LA; Yang Q; Li F; Xu H
    Biotech Histochem; 2012 Jan; 87(1):35-9. PubMed ID: 21838613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma.
    Higuchi I; Yasuda T; Yano M; Doki Y; Miyata H; Tatsumi M; Fukunaga H; Takiguchi S; Fujiwara Y; Hatazawa J; Monden M
    J Thorac Cardiovasc Surg; 2008 Jul; 136(1):205-12, 212.e1-3. PubMed ID: 18603077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional images reflect aggressiveness of endometrial carcinoma: estrogen receptor expression combined with 18F-FDG PET.
    Tsujikawa T; Yoshida Y; Kudo T; Kiyono Y; Kurokawa T; Kobayashi M; Tsuchida T; Fujibayashi Y; Kotsuji F; Okazawa H
    J Nucl Med; 2009 Oct; 50(10):1598-604. PubMed ID: 19759112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.